Medical/Pharmaceuticals
Brii Biosciences Adds US$100 Million to Advance its Late-Stage Monoclonal Antibody Combination Therapy, BRII-196/BRII-198, for Non-Hospitalized COVID-19 Patients
DURHAM, N.C. and BEIJING, Sept. 7, 2021 /PRNewswire/ -- Brii Biosciences
2021-09-07 19:04
5923
RedHill Biopharma's Opaganib Demonstrates Significant Decrease of Kidney Fibrosis
- COVID-19 and long COVID patients are at increased risk of developing kidney damage - Opaganib significantly decreased kidney fibrosis in a preclinical in vivo model - Renal fibrosis is a progressive process which occurs in patients with chronic kidney disease (CKD) and can ultimately lead to ...
2021-09-07 19:00
3638
Insilico Medicine and University of Cambridge Announce a Collaboration on Target Identification for Human Diseases Linked to Protein Liquid-liquid Phase Separation
HONG KONG, Sept. 7, 2021 /PRNewswire/ -- Insilico Medicine, an end-to-end artificial intelligence (AI) -driven drug discovery company, specialized in target discovery, small molecule chemistry, and clinical development, announced a collaboration with theUniversity of Cambridge. The agreement out...
2021-09-07 18:15
3638
RedHill Biopharma Presents Three New Analyses of Movantik Data at PAINWeek 2021
- Two new analyses of Movantik® (naloxegol) data evaluated the safety and efficacy of Movantik in a subgroup of patients aged ≥ 65 years - Analysis of Movantik effects on rapid and sustained improvement of both spontaneous and complete spontaneous bowel movements in the Movantik group vs. placeb...
2021-09-07 18:00
4555
Jubilant Biosys Limited announces the appointment of Mr. Giuliano Perfetti as Chief Executive Officer
BENGALURU, India, Sept. 7, 2021 /PRNewswire/ -- Today, Jubilant Biosys Limited
announced the appointment ofGiuliano Perfetti as its Chief Executive Officer.
2021-09-07 16:11
6167
MIM Software Inc. Announces AI Segmentation and Single Timepoint Dosimetry Capabilities for Molecular Radiotherapy
CLEVELAND, Sept. 7, 2021 /PRNewswire/ -- MIM Software Inc., a leading global provider of medical imaging software, announced today new innovations to MIM SurePlan™ MRT, its software package for Molecular Radiotherapy. MIM SurePlan MRT has received CE Mark approval for new artificial intelligence...
2021-09-07 15:00
4129
NeuExcell Therapeutics and Spark Therapeutics Announce Research Collaboration Agreement to Develop a Novel Gene Therapy for Huntington's Disease
-- Using NeuExcell's neuroregenerative gene therapy platform, the collaboration aims to develop an effective and safe treatment for patients suffering from Huntington's Disease. -- Spark Therapeutics' excellence in R&D and proprietary adeno-associated virus (AAV) vector gene therapy platform ma...
2021-09-07 12:00
4428
Major new study reveals that half of all people fear the internet and smartphones are damaging wellbeing
DHAHRAN, Saudi Arabia, Sept. 7, 2021 /PRNewswire/ -- As the world adjusts to a
post-pandemic reality dominated by technology, public concerns about the
dangers of over-consumption are gathering pace. According to a major new
survey[1] from Saudi-based cultural institute,Ithra
2021-09-07 08:01
5767
JW Therapeutics Announces NMPA Approval of Relmacabtagene Autoleucel Injection in China
* The first CAR-T product independently developed in China and approved as a Category 1 biologics product, and the sixth approved CAR-T product globally * Currently the only approved CAR-T product that has been simultaneously included in the National Significant New Drug Development Program, g...
2021-09-06 19:03
6094
GenScript ProBio Enters into Agreement with SYNIMMUNE for Manufacturing of their Innovative Antibody Drug
NANJING, China, Sept. 6, 2021 /PRNewswire/ -- GenScript ProBio is delighted to announce the signing of a manufacturing service agreement for Synimmune's innovative FLYSYN antibody project for clinical Phase II production. FLYSYN is a fms-like tyrosine kinase 3 (FLT3) specific antibody for the ...
2021-09-06 16:00
3643
Inspiration Capital Partners announces Investment in Beijing Loving Care International Pet Medical Center
SHANGHAI, Sept. 6, 2021 /PRNewswire/ -- Inspiration Capital Partners ("ICP") today announced an investment in Beijing Loving Care International Pet Medical Center ("Loving Care"). Founded in 2013, Loving Care is a leading premium specialty pet healthcare chain, focusing on providing high quality...
2021-09-06 15:32
4087
Kintor Pharma Included in Hong Kong Stock Connect Program
SUZHOU, China, Sept. 6, 2021 /PRNewswire/ -- Kintor Pharmaceutical Limited ("Kintor Pharma," HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecule and biological therapeutics, announced today that the company's stock has been included in the Hong Kong Stock Conn...
2021-09-06 11:30
4819
CStone Pharmaceuticals Included in the Hong Kong Stock Connect
SUZHOU, China, Sept. 6, 2021 /PRNewswire/ -- CStone Pharmaceuticals (HKEX: 2616, "CStone" or the "Company"), a leading biopharmaceutical company focused on researching, developing and commercializing innovative immuno-oncology therapies and precision medicines, announced that the Company has been...
2021-09-06 11:30
5092
Lunit AI Receives HSA Approval, Now Commercially Available in Singapore
* Lunit AI products for analyzing chest X-ray and mammograms now approved to support medical professionals ofSingapore, by detecting suspicious lesions with 96-99% accuracy * Applied in one of Singapore's leading healthcare center, with positive feedback from the users SEOUL, South Korea, Sep...
2021-09-06 09:30
2591
Gannex Announces Clinical Trial Application of ASC42, an FXR Agonist, for Treatment of Primary Biliary Cholangitis Accepted by China NMPA
SHANGHAI, Sept. 6, 2021 /PRNewswire/ -- Gannex Pharma Co., Ltd., a wholly owned company of Ascletis Pharma Inc. (HKEX:1672) announces today that the clinical trial application of ASC42 to treat patients with primary biliary cholangitis (PBC) has been accepted for review by China National Medical ...
2021-09-06 08:30
4172
The National Medical Products Administration (NMPA) issues product license for Abiraterone acetate 250 mg, Bioequivalance study conducted in India by Accutest Research Laboratories (I) Pvt. Ltd., one of the Top Indian CRO
BEIJING and MUMBAI, India, Sept. 6, 2021 /PRNewswire/ -- National Medical
Products Administration
2021-09-06 08:00
2848
Avidity Science Announces Agreement to Divest Lab Products & Harford Systems
WATERFORD, Wis., Sept. 4, 2021 /PRNewswire/ -- Avidity Science, a worldwide leader in life science research tools, today announces it has sold its subsidiaries of Lab Products, LLC. and Harford Systems, LLC. to Gen Cap America, Inc. ("Gen Cap"), a private equity firm focused on lower middle marke...
2021-09-04 00:00
5641
BGI safeguards Ethiopia-China Route with airport COVID-19 testing lab
SHENZHEN, China, Sept. 3, 2021 /PRNewswire/ -- From April to August, 2021, BGI's COVID-19 testing lab has helped 5,500 Chinese travelers safely fly out of the Addis Ababa Bole International Airport. In April, BGI set up the "Huo-Yan" laboratory, a COVID-19 testing lab, at the airport for pass...
2021-09-03 21:16
4351
Angel Yeast Launches Patented Saccharomyces Boulardii Bld-3, a Strain of Yeast Probiotic Effective Against Diarrhea
YICHANG, China, Sept. 2, 2021 /PRNewswire/ -- Angel Yeast Co., Ltd
2021-09-02 22:43
6319
Insilico Medicine Appoints the Former Chief Medical Officer of Schering Plough, Dr. Robert Spiegel, MD, FACP, as acting Chief Medical Officer (CMO) to Oversee the Clinical Translation of its Preclinical Pipeline Assets
SHANGHAI and NEW YORK, Sept. 2, 2021 /PRNewswire/ -- Insilico Medicine, an end-to-end AI-powered drug discovery company, today announced the appointment of Robert Spiegel as acting CMO to oversee the clinical translation of its preclinical pipeline assets. Dr. Spiegel brings over 35 years of exte...
2021-09-02 21:00
4403
Week's Top Stories
Most Reposted
Franchising & Licensing Asia 2026 Opens New Chapter Under MP, Strengthening Singapore's Position as Asia's Franchise and Licensing Hub
[Picked up by 309 media titles]
2026-07-30 10:45
J.P. Morgan Private Bank Earns Record 10 Accolades at The Asset Triple A Private Capital Awards 2026
[Picked up by 294 media titles]
2026-07-30 15:00ADA acquires Algonomy, strengthening its intelligent growth platform for a fully agentic experience
[Picked up by 290 media titles]
2026-07-30 15:30
MetaOptics and Elsoft partner to scale next-generation semiconductor optics manufacturing equipment
[Picked up by 286 media titles]
2026-07-30 18:15Most Read
Franchising & Licensing Asia 2026 Opens New Chapter Under MP, Strengthening Singapore's Position as Asia's Franchise and Licensing Hub
2026-07-30 10:45
14998
